Jennison Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,987
Closed -$7.99M 602
2023
Q1
$7.99M Sell
32,987
-25,969
-44% -$7.08M 0.01% 413
2022
Q4
$17.1M Sell
58,956
-54,544
-48% -$5.33M 0.02% 340
2022
Q3
$7.38M Sell
113,500
-68,946
-38% -$4.79M 0.01% 415
2022
Q2
$13.1M Buy
+182,446
New +$13.4M 0.01% 365
2020
Q3
Sell
-177,565
Closed -$20.1M 665
2020
Q2
$20.1M Sell
177,565
-47,369
-21% -$4.66M 0.02% 295
2020
Q1
$15M Sell
224,934
-51,496
-19% -$4.29M 0.02% 291
2019
Q4
$25.2M Buy
276,430
+741
+0.3% +$71.9K 0.03% 281
2019
Q3
$23.8M Sell
275,689
-29,204
-10% -$2.74M 0.03% 293
2019
Q2
$32M Sell
304,893
-6,127
-2% -$656K 0.03% 274
2019
Q1
$39M Buy
311,020
+29,949
+11% +$3.72M 0.04% 265
2018
Q4
$31.7M Buy
281,071
+57,700
+26% +$8.93M 0.04% 275
2018
Q3
$47.8M Buy
223,371
+61,586
+38% +$15.5M 0.04% 260
2018
Q2
$45.3M Sell
161,785
-66,873
-29% -$11.7M 0.04% 278
2018
Q1
$26.7M Buy
228,658
+24,458
+12% +$3.02M 0.03% 349
2017
Q4
$18.7M Buy
+204,200
New +$11.7M 0.02% 411
2015
Q4
Sell
-189,208
Closed -$11.5M 714
2015
Q3
$11.5M Buy
189,208
+1,069
+0.6% +$77.1K 0.01% 498
2015
Q2
$14.7M Buy
188,139
+1,363
+0.7% +$114K 0.01% 492
2015
Q1
$12.7M Buy
186,776
+85,924
+85% +$7.37M 0.01% 486
2014
Q4
$9.35M Sell
100,852
-4,116
-4% -$426K 0.01% 488
2014
Q3
$11.1M Buy
104,968
+113
+0.1% +$15.7K 0.01% 476
2014
Q2
$15M Sell
104,855
-8,869
-8% -$1.3M 0.01% 454
2014
Q1
$17.2M Buy
113,724
+563
+0.5% +$111K 0.02% 453
2013
Q4
$20.8M Sell
113,161
-12,203
-10% -$2.23M 0.02% 444
2013
Q3
$27.7M Buy
125,364
+1,253
+1% +$267K 0.03% 396
2013
Q2
$21.7M Buy
+124,111
New +$32.4M 0.02% 423

Other funds holding MDGL